Is the Western diet adequate in copper?

Journal of Trace Elements in Medicine and Biology

Volumn 25, Issue 4, 2011, Pages 204-212

  Klevay, Leslie M ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Copper; Dietary reference intakes; Epidemiology; Myelodysplastic syndrome; Myeloneuropathy

Indexed keywords

CERULOPLASMIN; COPPER; PLACEBO;

ALZHEIMER DISEASE; BONE DENSITY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL ANALYSIS; COPPER DEFICIENCY; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; MUSCULOSKELETAL DISEASE; NUTRITIONAL ASSESSMENT; NUTRITIONAL VALUE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

CHRONIC DISEASE; COPPER; DEVELOPED COUNTRIES; DIET; DIETARY SUPPLEMENTS; FEEDING BEHAVIOR; HUMANS;

ANIMALIA;

EID: 82855172097     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.08.146     Document Type: Review

References (199)

1. Burkitt D.P. Western diseases and what they encompass. Western diseases: their dietary prevention and reversibility 1994, 15-27. Humana Press, Totowa, NJ. N.J. Temple, D.P. Burkitt (Eds.).
2. King M.H., Elliott C.M. The diseases of gods: some newer threats to health. Oxford textbook of medicine 1996, 35-39. Oxford University Press, Oxford. D.J. Weatherall, J.G. Ledingham, D.A. Warrell (Eds.).
3. Mann J.T. Diseases of overnourished societies and the need for dietary change. Oxford textbook of medicine 1996, 1326-1332. Oxford University Press, Oxford. D.J. Weatherall, J.G. Ledingham, D.A. Warrell (Eds.).
4. Klevay L.M. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr 1975, 28:764-774.
5. Diet and health implications for reducing chronic disease risk 1989, National Academy Press, Washington, DC, p. 3, 7, 9, 274, 534.
6. Klevay L.M. Can copper deficiency cause ischemic heart disease?. Trace elements in man and animals - TEMA 7 1991, 11-13. Institute for Medical Research and Occupational Health, University of Zagreb, Zagreb. B. Momcilovic (Ed.).
7. Klevay L.M. Trace element and mineral nutrition in disease: ischemic heart disease. Clinical nutrition of the essential trace elements and minerals: the guide for health professionals. 2000, 251-271. Humana Press Inc., Totowa, NJ. J.D. Bogden, L.M. Klevay (Eds.).
8. Klevay L.M. Changing patterns of disease: some nutritional remarks. J Am Coll Nutr 1984, 3:149-158.
9. Davis G.K., Mertz W. Copper. Trace elements in human and animal nutrition 1987, 301-364. Academic Press, San Diego. W. Mertz (Ed.).
10. Klevay L.M. Copper and other chemical elements that affect the cardiovascular system. Toxicology of metals 1996, 921-928. CRC Lewis, Boca Raton. L.W. Chang, L. Magos, T. Suzuki (Eds.).
11. Klevay L.M. Cardiovascular disease from copper deficiency - a history. J Nutr 2000, 130. 489S-92S.
12. Klevay L.M., Wildman R.E. Meat diets and fragile bones: inferences about osteoporosis. J Trace Elem Med Biol 2002, 16:149-154.
13. Klevay L.M. Alzheimer's disease as copper deficiency. Med Hypotheses 2008, 70:802-807.
14. Klevay L.M., Copper Encyclopedia of dietary supplements 2010, 175-184. Informa Healthcare, London. P.M. Coates, J.M. Betz, M.R. Blackman, G.M. Cragg, M. Levine, J. Moss, J.D. White (Eds.).
15. Klevay L.M. Advances in cardiovascular-copper research. Trace elements in nutrition, health and disease 2002, 64-71. Institut Rosell, Montreal, Canada. G.N. Schrauzer (Ed.).
16. Mills C.F. Changing perspectives in studies of the trace elements and animal health. Trace elements in man and animals, TEMA 5 1985, 1-10. Commonwealth Agricultural Bureaux, Farnham Royal, UK. C.F. Mills, I. Bremner, J.K. Chesters (Eds.).
17. Recommended dietary allowances: protein, calcium, iron, vitamin A, vitamin B (thiamin), vitamin C (ascorbic acid), riboflavin, nicotinic acid, vitamin D 1941, National Research Council, Washington, DC, p. 1.
18. Dietary reference intakes: applications in dietary assessment 2000, National Academy of Sciences, Washington, DC, p. 2, 10, 22, 27, 30-31, 40, 46, 47, 82, 91, 95, 190, 191, 205, 255.
19. Dietary reference intakes: applications in dietary planning 2003, National Academy of Sciences, Washington, DC, p. 2, 3, 9, 10, 30, 71, 184, 254-261.
20. Dietary DRI reference intakes. The essential guide to nutrient requirements 2006, National Academy of Sciences, Washington, DC, p. vii, 1, 6, 9, 17, 23-26, 28, 30, 43, 425-428, 442, 443, 447-458.
21. Sanghvi T VAM, Baker J., Fiedler j. Vitamin and mineral deficiencies technical situation analysis: a report for the ten year strategy for the reduction of vitamin and mineral deficiencies 2007, S157-S219. United Nations University Press, Tokyo, especially S159, 160, 188, 189, 214. T. Sanghvi, M. Van Ameringen, J. Baker, J. Fiedler (Eds.).
22. Nutrient adequacy: assessment using food consumption surveys 1986, National Academy of Sciences, Washington, DC, p. 48, 50, 58, 85, 92, 93, 104-106.
23. Copper. Dietary reference intakes for vitamin A vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2001, National Academy of Sciences, Washington, DC, p. 224-57.
24. Dietary reference intakes: research synthesis workshop summary 2007, National Academy of Sciences, Washington, DC, p. 8, 9, 12, 170.
25. The development of DRIs: 1994-2004 2008, National Academy of Sciences, Washington, DC, p. 13, 19, 33, 39, 60.
26. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2001, National Academy Press, Washington, DC, p. xi-xiv, 55, 240, 243, 622, 648, 660.
27. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
28. Klevay L.M., Forbush J. Copper metabolism and the epidemiology of coronary heart disease. Nutr Rep Int 1976, 14:221-228.
29. Fan M.S., Zhao F.J., Fairweather-Tait S.J., Poulton P.R., Dunham S.J., McGrath S.P. Evidence of decreasing mineral density in wheat grain over the last 160 years. J Trace Elem Med Biol 2008, 22:315-324.
30. Thomas D. A study on the mineral depletion of the foods available to us as a nation over the period 1940 to 1991. Nutr Health 2003, 17:85-115.
31. White P.J., Broadley 1M.R. Historical variation in the mineral composition of edible horticultural products. J Hortic Sci Biotechnol 2005, 80:660-667.
32. Chew K.K. Proceedings of the North Americal Oyster workshop 1982, Louisiana University Press, Baton Rouge.
33. Schulte D.M., Burke R.P., Lipcius R.N. Unprecedented restoration of a native oyster metapopulation. Science 2009, 325:1124-1128.
34. Georgopoulos P.G., Wang S.W., Georgopoulos I.G., Yonone-Lioy M.J., Lioy P.J. Assessment of human exposure to copper: a case study using the NHEXAS database. J Expo Sci Environ Epidemiol 2006, 16:397-409.
35. Holden J.M., Wolf W.R., Mertz W. Zinc and copper in self-selected diets. JADA 1979, 75:23-28.
36. Klevay L.M., Reck S.J., Barcome D.F. Evidence of dietary copper and zinc deficiencies. JAMA 1979, 241:1916-1918.
37. Gibson R.S., Scythes C.A. Trace element intakes of women. Br J Nutr 1982, 48:241-248.
38. Klevay L.M. Magnesium, calcium, copper, and zinc in meals. Correlations related to the epidemiology of ischemic heart disease. Biol Trace Elem Res 1982, 4:95-104.
39. Buchet J.P., Lauwerys R., Vandevoorde A., Pycke J.M. Oral daily intake of cadmium, lead, manganese, copper, chromium, mercury, calcium, zinc and arsenic in Belgium: a duplicate meal study. Food Chem Toxicol 1983, 21:19-24.
40. Bunker V.W., Hinks L.J., Lawson M.S., Clayton B.E. Assessment of zinc and copper status of healthy elderly people using metabolic balance studies and measurement of leucocyte concentrations. Am J Clin Nutr 1984, 40:1096-1102.
41. Patterson K.Y., Holbrook J.T., Bodner J.E., Kelsay J.L., Smith J.C., Veillon C. Zinc, copper, and manganese intake and balance for adults consuming self-selected diets. Am J Clin Nutr 1984, 40:1397-1403.
42. Gibson R.S., Martinez O.B., MacDonald A.C. The zinc, copper, and selenium status of a selected sample of Canadian elderly women. J Gerontol 1985, 40:296-302.
43. Taper L.J., Oliva J.T., Ritchey S.J. Zinc and copper retention during pregnancy: the adequacy of prenatal diets with and without dietary supplementation. Am J Clin Nutr 1985, 41:1184-1192.
44. Moser P.B., Reynolds R.D., Acharya S., Howard M.P., Andon M.B., Lewis S.A. Copper, iron, zinc, and selenium dietary intake and status of Nepalese lactating women and their breast-fed infants. Am J Clin Nutr 1988, 47:729-734.
45. Rawson J.R., Medeiros D.M. Macronutrient, copper and zinc intakes of young adult males as determined by duplicate food samples and diet records. Nutr Rep Int 1989, 39:1149-1159.
46. Klevay L.M., Buchet J.P., Bunker V.W., Clayton B.E., Gibson R.S., Medeiros D.M., et al. Copper in the western diet (Belgium, Canada, UK and USA). Trace Elements in Man and Animals - TEMA 8 1993, 207-210. Verlag Media Touristik, Gersdorf, Germany. M. Anke, D. Meissner, C.F. Mills (Eds.).
47. Klevay L.M. Lack of a recommended dietary allowance for copper may be hazardous to your health. J Am Coll Nutr 1998, 17:322-326.
48. Pang Y., MacIntosh D.L., Ryan P.B. A longitudinal investigation of aggregate oral intake of copper. J Nutr 2001, 131:2171-2176.
49. Klevay L.M., Reck S.J., Jacob R.A., Logan G.M., Munoz J.M., Sandstead H.H. The human requirement for copper. I. Healthy men fed conventional, American diets. Am J Clin Nutr 1980, 33:45-50.
50. Pennington J.A., Wilson D.B. Daily intakes of nine nutritional elements: analyzed vs. calculated values. JADA 1990, 90:375-381.
51. Laryea M.D., Schnittert B., Kersting M., Wilhelm M., Lombeck I. Macronutrient, copper, and zinc intakes of young German children as determined by duplicate food samples and diet records. Ann Nutr Metab 1995, 39:271-278.
52. Ekmekcioglu C., Anderle H., Strauss B.G., Steffan I., Feyertag J., Marktl W. Calcium, magnesium, copper and zinc content of menu components: comparison of analysed with calculated values. Nahrung 1999, 43:311-316.
53. Hunt J.R., Vanderpool R.A. Apparent copper absorption from a vegetarian diet. Am J Clin Nutr 2001, 74:803-807.
54. Koenig J.S., Stojanovic M., Schauder P., Elmadfa I. Calcium, iron, zinc, copper, manganese and selenium concentrations in typical hospital diets. Forum Nutr 2003, 56:56-59.
55. Klevay L.M. Copper deficiency in Canadian octogenarians?. Rejuvenation Res 2008, 11:697-698.
56. Chiplonkar S.A., Agte V.V. Extent of error in estimating nutrient intakes from food tables versus laboratory estimates of cooked foods. Asia Pac J Clin Nutr 2007, 16:227-239.
57. Golden M.H.N. Severe malnutrition. Oxford textbook of medicine 1996, 1278-1296. Oxford University Press, Oxford. D.J. Weatherall, J.G. Ledingham, D.A. Warrell (Eds.).
58. Pepys M.B. The acute phase response and C-reactive protein. Oxford textbook of medicine 1996, 1527-1533. Oxford University Press, Oxford. D.J. Weatherall, J.G. Ledingham, D.A. Warrell (Eds.).
59. Klevay L.M., Saari J.T. Comparative responses of rats to different copper intakes and modes of supplementation. Proc Soc Exp Biol Med 1993, 203:214-220.
60. Evans G.W., Cornatzer N.F., Cornatzer W.E. Mechanism for hormone-induced alterations in serum ceruloplasmin. Am J Physiol 1970, 218:613-615.
61. Kincaid R.L. Toxicity of ammonium molybdate added to drinking water of calves. J Dairy Sci 1980, 63:608-610.
62. Klevay L.M. Metabolic interactions among cholesterol, cholic acid and copper. Nutr Rep Int 1982, 26:405-414.
63. Kennedy M.L., Failla M.L., Smith J.C. Influence of genetic obesity on tissue concentrations of zinc, copper, manganese and iron in mice. J Nutr 1986, 116:1432-1441.
64. Clegg M.S., Ferrell F., Keen C.L. Hypertension-induced alterations in copper and zinc metabolism in Dahl rats. Hypertension 1987, 9:624-628.
65. Klevay L.M. Dietary cholesterol lowers liver copper in rabbits. Biol Trace Elem Res 1988, 16:51-57.
66. Vlad M., Bordas E., Tomus R., Sava D., Farkas E., Uza G. Effect of copper sulfate on experimental atherosclerosis. Biol Trace Elem Res 1993, 38:47-54.
67. Vlad M., Uza G., Zirbo M., Olteanu D. Free radicals, ceruloplasmin, and copper concentration in serum and aortic tissue in experimental atherosclerosis. Nutrition 1995, 11:588-591.
68. Xu H., Sakakibara S., Morifuji M., Salamatulla Q., Aoyama Y. Excess dietary histidine decreases the liver copper level and serum alanine aminotransferase activity in Long-Evans Cinnamon rats. Br J Nutr 2003, 90:573-579.
69. Kinsman G.D., Howard A.N., Stone D.L., Mullins P.A. Studies in copper status and atherosclerosis. Biochem Soc Trans 1990, 18:1186-1188.
70. Oster O., Dahm M., Oelert H. Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorous) in heart tissue of patients with coronary heart disease correlated with physiological parameters of the heart. Eur Heart J 1993, 14:770-774.
71. Wang X.L., Adachi T., Sim A.S., Wilcken D.E. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 1998, 18:1915-1921.
72. Bo S., Durazzo M., Gambino R., Berutti C., Milanesio N., Caropreso A., Gentile L., et al. Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults. J Nutr 2008, 138:305-310.
73. de la Sierra A., Larrousse M. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension. J Hum Hypertens 2010, 24:373-379.
74. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc 2006, 81:1371-1384.
75. Kelkar P., Chang S., Muley S.A. Response to oral supplementation in copper deficiency myeloneuropathy. J Clin Neuromuscul Dis 2008, 10:1-3.
76. Jaiser S.R., Winston G.P. Copper deficiency myelopathy. J Neurol 2010, 257:869-881.
77. Prodan C.I., Rabadi M., Vincent A.S., Cowan L.D. Copper supplementation improves functional activities of daily living in adults with copper deficiency. J Clin Neuromuscul Dis 2011, 12:122-128.
78. Klevay L.M. Copper as a supplement to iron for hemoglobin building in the rat (Hart et al., 1928). J Nutr 1997, 127. 1034S-6S.
79. Prodan C.I., Holland N.R., Wisdom P.J., Burstein S.A., Bottomley S.S. CNS demyelination associated with copper deficiency and hyperzincemia. Neurology 2002, 59:1453-1456.
80. Goodman B.P., Bosch E.P., Ross M.A., Hoffman-Snyder C., Dodick D.D., Smith B.E. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol Neurosurg Psychiatry 2009, 80:524-527.
81. Goodman B.P., Chong B.W., Patel A.C., Fletcher G.P., Smith B.E. Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. Am J Neuroradiol 2006, 27:2112-2114.
82. Weihl C.C., Lopate G. Motor neuron disease associated with copper deficiency. Muscle Nerve 2006, 34:789-793.
83. Zara G., Grassivaro F., Brocadello F., Manara R., Pesenti F.F. Case of sensory ataxic ganglionopathy-myelopathy in copper deficiency. J Neurol Sci 2009, 277:184-186.
84. Prodan C.I., Bottomley S.S., Holland N.R., Lind S.E. Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement. J Neurol Neurosurg Psychiatry 2006, 77:1092-1093.
85. Spencer J.C. Direct relationship between the body's copper/zinc ratio, ventricular beats, and sudden coronary death. Am J Clin Nutr 1979, 32:1184-1185.
86. Eaton-Evans J., McIlrath E.M., Jackson W.E., McCartney H., Strain J.J. Copper supplementation and the maintenance of bone mineral density in middle-aged women. J Trace Elem Exp Med 1996, 9:87-94.
87. Rock E., Mazur A., O'Connor J.M., Bonham M.P., Rayssiguier Y., Strain J.J. The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in middle-aged healthy volunteers. Free Radic Biol Med 2000, 28:324-329.
88. Tamura T., Turnlund J.R. Effect of long-term, high-copper intake on the concentrations of plasma homocysteine and B vitamins in young men. Nutrition 2004, 20:757-759.
89. Bugel S., Harper A., Rock E., O'Connor J.M., Bonham M.P., Strain J.J. Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women. Br J Nutr 2005, 94:231-236.
90. Klevay L.M., Medeiros D.M. Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations about copper. J Nutr 1996, 126. 2419S-26.
91. Baker A., Harvey L., Majask N.G., Fairweather T.S., Flynn A., Cashman K. Effect of dietary copper intakes on biochemical markers of bone metabolism in healthy adult males. Eur J Clin Nutr 1999, 53:408-412.
92. Klevay L.M., Inman L., Johnson L.K., Lawler M., Mahalko J.R., Milne D.B., Lukaski H.C., Bolonchuk W., Sandstead H.H. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984, 33:1112-1118.
93. Reiser S., Powell A., Yang C.Y., Canary J.J. Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr Rep Int 1987, 36:641-649.
94. Reiser S., Smith J.C., Mertz W., Holbrook J.T., Scholfield D.J., Powell A.S., et al. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr 1985, 42:242-251.
95. Klevay L.M., Canfield W.K., Gallagher S.K., Henriksen L.K., Lukaski H.C., Bolonchuk W., Johnson L.K., Milne D.B., Sandstead H.H. Decreased glucose tolerance in two men during experimental copper depletion. Nutr Rep Int 1986, 33:371-382.
96. Lukaski H.C., Klevay L.M., Milne D.B. Effects of dietary copper on human autonomic cardiovascular function. Eur J Appl Physiol 1988, 58:74-80.
97. Majsak-Newman G., Dainty J.R., Lewis D.J., Langford N.J., Crews H.M., Fairweather-Tait S.J. Adaptive responses in men fed low- and high-copper diets. Br J Nutr 2003, 90:161-168.
98. Turnlund J.R., Keyes W.R., Anderson H.L., Acord L.L. Copper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65Cu. Am J Clin Nutr 1989, 49:870-878.
99. Turnlund J.R., Swanson C.A., King J.C. Copper absorption and retention in pregnant women fed diets based on animal and plant proteins. J Nutr 1983, 113:2346-2352.
100. Turnlund J.R., Keen C.L., Smith R.G. Copper status and urinary and salivary copper in young men at three levels of dietary copper. Am J Clin Nutr 1990, 51:658-664.
101. Turnlund J.R., Scott K.C., Peiffer G.L., Jang A.M., Keyes W.R., Keen C.L., et al. Copper status of young men consuming a low-copper diet. Am J Clin Nutr 1997, 65:72-78.
102. Turnlund J.R. Human whole-body copper metabolism. Am J Clin Nutr 1998, 67. 960S-4S.
103. Turnlund J.R., Keyes W.R., Peiffer G.L., Scott K.C. Copper absorption, excretion, and retention by young men consuming low dietary copper determined by using the stable isotope 65Cu. Am J Clin Nutr 1998, 67:1219-1225.
104. Hegsted D.M., Nicolosi R.J. Do formula diets attenuate the serum cholesterol response to dietary fats?. J Vasc Med Biol 1990, 2:69-73.
105. Hegsted D.M., Ausman L.M., Johnson J.A., Dallal G.E. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993, 57:875-883.
106. Strause L., Saltman P., Smith K.T., Bracker M., Andon M.B. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994, 124:1060-1064.
107. Wan Y., Vinson J.A., Etherton T.D., Proch J., Lazarus S.A., Kris-Etherton P.M. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001, 74:596-602.
108. Klevay L.M. Extra dietary copper inhibits LDL oxidation. Am J Clin Nutr 2002, 76:687-688.
109. Clemons T.E., Kurinij N., Sperduto R.D. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004, 122:716-726.
110. Witte K.L.A., Nikitin N.P., Parker A.C., von Haehling S., Volk H.-D., Anker S.D., et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005, 26:2238-2244.
111. Klevay L.M. Heart failure improvement from a supplement containing copper. Eur Heart J 2006, 27:117.
112. Copper. (COMA) Report on health and social subjects 41: dietary reference values (DRVs) for food energy and nutrients for the UK 1991, The Stationery Office, London, p. 171-3.
113. Copper. Nutrient and energy intakes for the European Community 1993, Commission of the European Community, Luxembourg, p. 197-201.
114. Nutrient reference values for Australia and New Zealand 2006, Government of Australia, Melbourne, p. 171-4.
115. Osler W. The principles and practice of medicine 1892, D. Appleton and Company. 1st ed.
116. Terris M. Goldberger on pellagra 1964, Louisiana State University Press, Baton Rouge.
117. Recommended dietary allowances 1974, National Academy of Sciences, Washington, DC, p. 9.
118. Milne D.B., Johnson P.E., Klevay L.M., Sandstead H.H. Effect of copper intake on balance, absorption, and status indices of copper in men. Nutr Res 1990, 10:975-986.
119. Klevay L.M. And so spake Goldberger in 1916: pellagra is not infectious. J Am Coll Nutr 1997, 16:290-292.
120. Gyorgy P. The curative factor (vitamin H) for egg white injury, with particular reference to its presence in different foodstuffs and in yeast. J Biol Chem 1939, 131:733-744.
121. Williams R.R. Toward the conquest of beriberi 1961, Harvard University Press, Cambridge. 1st ed.
122. Menczel J., Reshef A., Schwartz A., Guggenheim K., Hegsted D.M., Stare F.J. Aortic calcification in Israel. An epidemiological study. Arch Environ Health 1971, 22:667-671.
123. Cox J.M., Gideon D., Rogers F.J. Incidence of osteophytic lipping of the thoracic spine in coronary heart disease: results of a pilot study. J Am Osteopath Assoc 1983, 82:837-838.
124. Browner W.S., Seeley D.G., Vogt T.M., Cummings S.R. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 1991, 338:355-358.
125. Banks L.M., Lees B., MacSweeney J.E., Stevenson J.C. Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?. Eur J Clin Invest 1994, 24:813-817.
126. Uyama O., Yoshimoto Y., Yamamoto Y., Kawai A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997, 28:1730-1732.
127. Kado D.M., Browner W.S., Blackwell T., Gore R., Cummings S.R. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 2000, 15:1974-1980.
128. Jorgensen L., Engstad T., Jacobsen B.K. Bone mineral density in acute stroke patients: low bone mineral density may predict first stroke in women. Stroke 2001, 32:47-51.
129. Celik C., Altunkan S., Yildirim M.O., Akyuz M. Relationship between decreased bone mineral density and subclinical atherosclerosis in postmenopausal women. Climacteric 2010, 13:254-258.
130. Tarakida A., Iino K., Abe K., Taniguchi R., Higuchi T., Mizunuma H., et al. Hypercholesterolemia accelerates bone loss in postmenopausal women. Climacteric 2011, 14:105-111.
131. Gerber Y., Melton L.J., Weston S.A., Roger V.L. Association between myocardial infarction and fractures: an emerging phenomenon. Circulation 2011, 124:297-303.
132. Dann W.J., Darby W.J. The appraisal of nutritional status (nutriture) in humans; with especial reference to vitamin deficiency disease. Physiol Rev 1945, 25:326-346.
133. Klevay L.M. Dietary requirements for trace elements in humans. Trace element-analytical chemistry in medicine and biology 1987, 43-60. Walter de Gruyter & Co., Berlin. P. Brätter, P. Schramel (Eds.).
134. Galen R.S., Gambino S.R. Beyond normality: the predictive value and efficiency of medical diagnoses 1975, Wiley, New York.
135. Harvey L.J., McArdle H.J. Biomarkers of copper status: a brief update. Br J Nutr 2008, 99(Suppl. 3):S10-S13.
136. de Romana D.L., Olivares M., Uauy R., Araya M. Risks and benefits of copper in light of new insights of copper homeostasis. J Trace Elem Med Biol 2011, 25:3-13.
137. Prohaska J.R. Biochemical changes in copper deficiency. J Nutr Biochem 1990, 1:452-461.
138. Iskandar M., Swist E., Trick K.D., Wang B., L'Abbe M.R., Bertinato J. Copper chaperone for Cu/Zn superoxide dismutase is a sensitive biomarker of mild copper deficiency induced by moderately high intakes of zinc. Nutr J 2005, 4:35.
139. Milne D.B. Assessment of copper nutritional status. Clin Chem 1994, 40:1479-1484.
140. Bergomi M., Rovesti S., Vinceti M., Vivoli R., Caselgrandi E., Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 1997, 11:166-169.
141. Mielcarz G.W., Howard A.N., Williams N.R., Kinsman G.D., Moriguchi E., Moriguchi Y., et al. Copper and zinc status as a risk factor for ischemic heart disease: a comparison between Japanese in Brazil and Okinawa. J Trace Elem Exp Med 1997, 10:29-35.
142. Johnson W.T., Johnson L.A., Lukaski H.C. Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats. J Nutr Biochem 2005, 16:682-692.
143. Lynch S.M., Frei B., Morrow J.D., Roberts L.J., Xu A., Jackson T., Reyna R., Klevay L.M., Vita J.A., Keaney J.F. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol 1997, 17:2975-2981.
144. Lavi S., Yang E.H., Prasad A., Mathew V., Barsness G.W., Riyal C.S., et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008, 51:127-133.
145. Gerzer R., hme E., Hofmann F., Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. Febs Lett 1981, 132:71-74.
146. Tamura T., Hong K.H., Mizuno Y., Johnston K.E., Keen C.L. Folate and homocysteine metabolism in copper-deficient rats. Biochim Biophys Acta 1999, 1427:351-356.
147. Klevay L.M. How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease. Cell Mol Biol 2006, 52:11-15.
148. Kennerson M.L., Nicholson G.A., Kaler S.G., Kowalski B., Mercer J.F., Tang J., et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet 2010, 86:343-352.
149. Wester P.O. Trace elements in human myocardial infarction determined by neutron activation analysis. Acta Med Scand 1965, 178:765-788.
150. Wester P.O. Trace elements in the coronary arteries in the presence and absence of atherosclerosis. Atherosclerosis 1971, 13:395-412.
151. Anderson T.W., Neri L.C., Schreiber G.B., Talbot F.D., Zdrojewski A. Ischemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J 1975, 113:199-203.
152. Chipperfield B., Chipperfield J.R. Differences in metal content of the heart muscle in death from ischemic heart disease. Am Heart J 1978, 95:732-737.
153. Aalbers T.G. Cardiovascular diseases and trace elements 1984, Drukkerij Blok en Zonen, Dieren.
154. Tilson M.D. Decreased hepatic copper levels. A possible chemical marker for the pathogenesis of aortic aneurysms in man. Arch Surg 1982, 117:1212-1213.
155. Penttila: O., Neuvonen P.J., Vuori E., Himberg J.-J., Siltanen P., Ja:rvinen A., Merikallio E. Auricular myocardial cation concentrations in certain heart diseases in man. Trace Elements Med 1986, 3:47-51.
156. Zama N., Towns R.L. Cardiac copper, magnesium, and zinc in recent and old myocardial infarction. Biol Trace Elem Res 1986, 10:201-208.
157. Russo C., Olivieri O., Girelli D., Faccini G., Zenari M.L., Lombardi S., Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998, 16:1267-1271.
158. Plantin L.-O., Lying-Tunell U., Kristensson K. Trace elements in the human central nervous system studied with neutron activation analysis. Biol Trace Element Res 1987, 13:69-75.
159. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 1996, 143:137-142.
160. Kessler H., Pajonk F.G., Meisser P., Schneider-Axmann T., Hoffmann K.H., Supprian T., et al. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. J Neural Transm 2006, 113:1763-1769.
161. Allred J.W., Aulino J.M. Hypocupremia-associated myelopathy. J Comput Assist Tomogr 2007, 31:157-159.
162. Magaki S., Raghavan R., Mueller C., Oberg K.C., Vinters H.V., Kirsch W.M. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett 2007, 418:72-76.
163. Bach J.P., Kumar N., Depboylu C., Noelker C., Klockgether T., Bacher M., et al. Copper deficiency associated with severe neurological disorder - a genetic work-up of possible mutations in copper transport proteins. J Neurol Sci 2010, 291:95-97.
164. Pajonk F.G., Kessler H., Supprian T., Hamzei P., Bach D., Schweickhardt J., et al. Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis 2005, 8:23-27.
165. Vural H., Demirin H., Kara Y., Eren I., Delibas N. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol 2010, 24:169-173.
166. Milachowski K.A., Matzen K.A. Mineral- und Spurenelementstoffwechelsto:rungen bei der Koxarthrose. Z Orthrop 1982, 120:828-832.
167. Howard G., Andon M., Bracker M., Saltman P., Strause L. Low serum copper, a risk factor additional to low dietary calcium in postmenopausal bone loss. J Trace Elem Exp Med 1992, 5:23-31.
168. Gur A., Colpan L., Nas K., Cevik R., Sarac J., Erdogan F., Duz M.Z. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab 2002, 20:39-43.
169. Chaudhri M.A., Kemmler W., Harsch I., Watling R.J. Plasma copper and bone mineral density in osteopenia: an indicator of bone mineral density in osteopenic females. Biol Trace Elem Res 2009, 129:94-98.
170. Milachowski K.A. Investigation of ischaemic necrosis of the femoral head with trace elements. Int Orthop 1988, 12:323-330.
171. Conlan D., Korula R., Tallentire D. Serum copper levels in elderly patients with femoral-neck fractures. Age Ageing 1990, 19:212-214.
172. Vivoli G., Bergomi M., Rovesti S., Pinotti M., Caselgrandi E. Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension. Biol Trace Elem Res 1995, 49:97-106.
173. Kotur-Stevuljevic J., Spasic S., Jelic-Ivanovic Z., Spasojevic-Kalimanovska V., Stefanovic A., Vujovic A., et al. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients. Clin Biochem 2008, 41:1067-1073.
174. Dubick M.A., Keen C.L., DiSilvestro R.A., Eskelson C.D., Ireton J., Hunter G.C. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1999, 220:39-45.
175. Landmesser U., Merten R., Spiekermann S., Buttner K., Drexler H., Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000, 101:2264-2270.
176. Yamashita K., Takahiro K., Kamezaki F., Adachi T., Tasaki H. Decreased plasma extracellular superoxide dismutase level in patients with vasospastic angina. Atherosclerosis 2007, 191:147-152.
177. Wand G.S., May C., May V., Whitehouse P.J., Rapoport S.I., Eipper B.A. Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF. Neurology 1987, 37:1057-1061.
178. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., et al. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 1992, 59:776-779.
179. Mutisya E.M., Bowling A.C., Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994, 63:2179-2184.
180. Chagnon P., Betard C., Robitaille Y., Cholette A., Gauvreau D. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 1995, 6:711-715.
181. Connor J.R., Tucker P., Johnson M., Snyder B. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 1993, 159:88-90.
182. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation. J Neuropathol Exp Neurol 1993, 52:580-585.
183. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res 1994, 24:336-340.
184. Parker W.D., Parks J., Filley C.M., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994, 44:1090-1096.
185. Gonzalez-Lima F., Valla J., Matos-Collazo S. Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients. Brain Res 1997, 752:117-126.
186. Wong-Riley M., Antuono P., Ho K.C., Egan R., Hevner R., Liebl W., et al. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res 1997, 37:3593-3608.
187. Snaedal J., Kristinsson J., Gunnarsdottir S., Olafsdottir, Baldvinsson M., Johannesson T. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. a case-control study. Dement Geriatr Cogn Disord 1998, 9:239-242.
188. Casado A., Encarnacion Lopez-Fernandez M., Concepcion Casado M., de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008, 33:450-458.
189. Ojaimi J., Masters C.L., McLean C., Opeskin K., McKelvie P., Byrne E. Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Ann Neurol 1999, 46:656-660.
190. de la Monte S.M., Luong T., Neely T.R., Robinson D., Wands J.R. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest 2000, 80:1323-1335.
191. Maurer I., Zierz S., Moller H.J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000, 21:455-462.
192. Verwer R.W., Jansen K.A., Sluiter A.A., Pool C.W., Kamphorst W., Swaab D.F. Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits. Exp Neurol 2000, 163:440-451.
193. Bosetti F., Brizzi F., Barogi S., Mancuso M., Siciliano G., Tendi E.A., et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002, 23:371-376.
194. Parker W.D., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990, 40:1302-1303.
195. Parker W.D., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., Cullum C.M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 1994, 44:1086-1090.
196. Valla J., Berndt J.D., Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 2001, 21:4923-4930.
197. Hamblet N.S., Ragland B., Ali M., Conyers B., Castora F.J. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 2006, 27:398-408.
198. Capo C.R., Arciello M., Squitti R., Cassetta E., Rossini P.M., Calabrese L., Rossi L. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients. Biometals 2008, 21:367-372.
199. Kish S.J. Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase. Ann N Y Acad Sci 1997, 826:218-228.